The easy to navigate, intuitive platform offers clinician-led access to GLP-1 care and a growing catalog of health-related medications and support services, with a patient experience designed around simplicity, safety, and transparent pricing
National Science and Technology Major Project of China Key New Drug Creation and Manufacturing Program 2018ZX09735001 (M.-W.W.) and 2018ZX09711002002005 (D.Y.)
Clinical trials show that retatrutide could be the most powerful drug to be developed for the treatment of obesity
In tumors, elevated extracellular K + is a characteristic of the TME, which may lead to a significant reduction in glycolysis intermediates and essential amino acids inside T cells, inhibiting T cell effector function while maintaining cell survival
In markets across Asia, Africa, Latin America, and parts of Eastern Europe where cold-chain infrastructure is unreliable, oral GLP-1s have the potential to unlock access to hundreds of millions of patients who could never have reliably received injectable therapy
For many post-op patients in the UK, high-dose oral B12 supplements can now replace injections especially when taken consistently as part of a complete multivitamin routine